Nutritional status in patients with COVID-19 and cancer: the experience of the National Cancer Institute in Mexico

被引:3
|
作者
Perez Camargo, Dana Aline [1 ,7 ]
Vargas Gutierrez, Gaspar [1 ]
Rivera Franco, Monica M. [6 ]
Labana Ramirez, Anabel [1 ]
Castro Herrera, Monserrat [1 ]
Urbalejo Ceniceros, Victor Itai [2 ]
Copca Mendoza, Erika Thalia [1 ]
Loyola Serrano, Osiris [1 ]
Baltazar Luna, Erendira [1 ]
Meneses Garcia, Abelardo [4 ]
Herrera Gomez, Angel [5 ]
Gonzalez Enciso, Aaron [3 ]
Sevilla Gonzalez, Maria de la Luz [7 ]
机构
[1] Inst Nacl Cancerol, Dept Nutr, Ave San Fernando 22,Belisario Dominguez Secc XVI, Mexico City 14080, DF, Mexico
[2] Inst Nacl Cancerol, Dept Hematol, Mexico City, DF, Mexico
[3] Inst Nacl Cancerol, Dept Surg, Mexico City, DF, Mexico
[4] Inst Nacl Cancerol, Dept Gen Directorship, Mexico City, DF, Mexico
[5] Inst Nacl Cancerol, Dept Med Directorship, Mexico City, DF, Mexico
[6] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Hematol & Oncol, Mexico City, DF, Mexico
[7] Inst Politecn Nacl, Fac Med, Postgrad & Res Dept, Mexico City, DF, Mexico
关键词
Body mass index; Cancer; COVID-19; Mortality; Nutrition;
D O I
10.20960/nh.03683
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Background: nutritional status might vary according to different underlying illnesses such as cancer or infectious diseases, including COVID-19. In this context, data from developing countries remain scarce. Objectives: the objective of this study was to assess the nutritional status and outcomes of Mexican cancer patients diagnosed with COVID-19 at a tertiary care center. Methods: this was a retrospective study including 121 consecutive cancer patients diagnosed with COVID-19 at the National Cancer Institute, Mexico City, during four months. Results: the most frequent oncological diagnoses were gynecological (19 %) and hematological (17 %). Most patients were overweight (35 %). In the univariate analysis, >= 65 years, intubation, hypoalbuminemia, high creatinine, lymphopenia, nutrition-impact symptoms, and ECOG 2-4 were statistically associated with lower survival. The median survival of the cohort was 41 days. Conclusions: to our best knowledge, this is the first study of its kind performed in Mexico, and as other studies from other regions, our results might aid in identifying cancer patients most at risk for severe COVID-19, and could be potentially useful to enhance public health messaging on self-isolation and social distancing among Mexican cancer patients.
引用
收藏
页码:1263 / 1268
页数:6
相关论文
共 50 条
  • [31] Psychological Status during COVID-19 Pandemic on the Patients with Cancer
    Novin, Kambiz
    Hassanlouei, Babak
    Motamed, Mahtab
    Faraji, Saba
    Najafi, Masume
    Fadavi, Pedram
    Sanei, Mastaneh
    Jolfaei, Atefeh Ghanbari
    Garousi, Maryam
    MIDDLE EAST JOURNAL OF CANCER, 2022, 13 (04) : 648 - 656
  • [32] MANAGING CANCER COSTS DURING COVID-19: FINDINGS FROM THE NATIONAL CANCER INSTITUTE'S CANCER INFORMATION SERVICE
    Vanderpool, Robin C.
    Petraglia, Elizabeth
    Huang, Grace C.
    Wilson, Ashley
    Maynard, Candace D.
    ANNALS OF BEHAVIORAL MEDICINE, 2022, 56 (SUPP 1) : S393 - S393
  • [33] Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients
    Gundavda, Manit K.
    Gundavda, Kaival K.
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2021, 22 (10)
  • [34] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Sinha, Saptarshi
    Kundu, Chanakya Nath
    MEDICAL ONCOLOGY, 2021, 38 (09)
  • [35] Cancer or COVID-19? A Review of Recommendations for COVID-19 Vaccination in Cancer Patients
    Manit K. Gundavda
    Kaival K. Gundavda
    Current Treatment Options in Oncology, 2021, 22
  • [36] Cancer and COVID-19: Why are cancer patients more susceptible to COVID-19?
    Saptarshi Sinha
    Chanakya Nath Kundu
    Medical Oncology, 2021, 38
  • [37] A year of experience with COVID-19 in patients with cancer: A nationwide study
    Khosravifar, Mina
    Koolaji, Sogol
    Rezaei, Negar
    Ghanbari, Ali
    Hashemi, Seyedeh Melika
    Ghasemi, Erfan
    Bitaraf, Ali
    Tabatabaei-Malazy, Ozra
    Rezaei, Nazila
    Fateh, Sahar Mohammadi
    Dilmaghani-Marand, Arezou
    Haghshenas, Rosa
    Kazemi, Ameneh
    Pakatchian, Erfan
    Kompani, Farzad
    Djalalinia, Shirin
    CANCER REPORTS, 2023, 6 (01)
  • [38] COVID-19 amongst cancer patients: An experience from Oman
    Al Bahrani, Bassim Jaffar
    Mehdi, Itrat
    Khamis, Faryal Ali
    Al Farsi, Abdulaziz Mohammed
    Al Fandi, Fatma
    Al Lawati, Najla Ali
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (11) : 2563 - 2569
  • [39] COVID-19 in Patients With Cancer
    Pettit, N.
    Bischof, J. J.
    Kline, J.
    ANNALS OF EMERGENCY MEDICINE, 2021, 78 (02) : S22 - S22
  • [40] COVID-19 in Patients with Cancer
    Nowroozi, Ali
    Razi, Sepideh
    Sahu, Kamal Kant
    Grizzi, Fabio
    Arends, Jann
    Keshavarz-Fathi, Mahsa
    Rezaei, Nima
    CORONAVIRUS DISEASE - COVID-19, 2021, 1318 : 315 - 331